Jeremy Bender, Day One Biopharmaceuticals CEO
Day One goes to the market for $150M as biotech kicks off NDA request for pediatric brain cancer drug
Day One Biopharmaceuticals will offer up more than 11.5 million shares to nab $150 million in gross proceeds after the biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
